Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor

Ping Hui Tseng, Yu Chieh Wang, Shu Chuan Weng, Jing Ru Weng, Chang Shi Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching Yu Chen, Sandra E. Dunn, Michael Pollak, Ching Shih Chen

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint Dive into the research topics of 'Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences